Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Keep informed on insider trading with our comprehensive news coverage. Explore the latest insider stock trades, follow insider trading activity, and dive into detailed reports on recent cases. Whether you’re monitoring the markets or interested in today’s top headlines, our insider trades tracker provides timely insights and updates.
Wu Xiaobin, the President, COO, and GM of China at BeiGene , Ltd. (NASDAQ:BGNE), a outstanding biotechnology firm with a market capitalization of $22 billion and spectacular gross revenue margins of 84%, not too long ago disclosed a transaction involving…
Enrique Lores, President and CEO of HP Inc. (NYSE:HPQ), just lately executed a big inventory sale as a part of a pre-established buying and selling plan. On December 9, Lores bought 137,094 shares of frequent inventory at a mean worth…
On December 10, Nxu, Inc. (NASDAQ:NXU) disclosed in an SEC submitting that Britt E. Ide, a director of the corporate, offered shares amounting to roughly $97,918. Based on InvestingPro information, this insider sale comes as the corporate faces vital challenges,…
Roland Goette, Government Vice President and President of EMEA at Becton Dickinson & Co (NYSE:BDX), has not too long ago bought a good portion of his holdings within the firm. In response to a latest SEC submitting, Goette bought 5,121…
Jessica Billingsley, a director at Nxu, Inc. (NASDAQ:NXU), lately offered 14,455 shares of the corporate’s Class A typical inventory. The shares had been offered on November 25, 2024, at a worth of roughly $0.2622 per share, amounting to a complete…
Richard Todd Schwartz, CEO of Rush Road Interactive, Inc. (NYSE:RSI), an organization whose inventory has surged over 200% year-to-date and maintains a market capitalization of $3.05 billion, not too long ago offered shares amounting to roughly $2.63 million, in line…
BURLINGAME, CA—Cero Therapeutics Holdings, Inc. (NASDAQ:CERO), a micro-cap biotech firm with a market capitalization of $16.44 million, lately skilled important inventory gross sales by YK Bioventures Alternatives Fund I, L.P., a significant shareholder. In accordance with a latest SEC submitting,…
Robin Shane Readnour, a director at AN2 Therapeutics, Inc. (NASDAQ:ANTX), has lately elevated his stake within the firm by way of a number of purchases of widespread inventory. Based on a latest SEC submitting, Readnour acquired a complete of 60,000…
Following these transactions, Ram holds 282,832 shares instantly, whereas extra shares are held not directly by means of numerous trusts and by his partner. These transactions have been carried out beneath Rule 10b5-1 Buying and selling Plans, which had been…
This transaction will increase the whole shares owned by JCP Funding Partnership to eight,290,675, whereas JCP Administration manages further shares held in varied accounts. The funding underscores the continued curiosity and involvement of JCP Funding Partnership in Progressive Meals Holdings,…